Related Experiment Video
Updated: May 15, 2026
05:12
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Adiponectin Fortifies White Matter After Chronic Hypoperfusion-Induced Vascular Dementia
Wanying Miao1, Fei Xu1,2, Hongjian Pu1,2
1Department of Neurology (W.M., F.X., H.P., J.S., J.L., T.-W.M., Q.T., A.P., J.B., L.J., R.A.S., J.C., X.H.), University of Pittsburgh, PA.
Stroke
|May 14, 2026
Summary
Adiponectin enhances white matter integrity in vascular dementia by protecting oligodendrocytes and promoting microglial repair. This offers a new therapeutic avenue for cognitive impairment.
Area of Science:
- Neuroscience
- Endocrinology
- Pathology
Background:
- Vascular cognitive impairment and dementia (VCID) involves white matter demyelination and oligodendrocyte loss.
- Low adiponectin levels correlate with increased white matter lesions and cognitive decline.
- Adiponectin and its agonist adipoRon were investigated for their effects on white matter integrity in a VCID model.
Purpose of the Study:
- To evaluate the therapeutic potential of adiponectin and adipoRon in chronic hypoperfusion-induced VCID.
- To investigate the impact of adiponectin and adipoRon on white matter integrity and cognitive function.
- To elucidate the cellular mechanisms underlying adiponectin's protective effects on white matter.
Main Methods:
- A mouse model of VCID was established using asymmetrical common carotid artery stenosis.
- White matter integrity was assessed using immunohistochemistry, electron microscopy, electrophysiology, and diffusion tensor imaging.
- Cognitive function was evaluated through behavioral tests, and in vitro studies used organotypic slice cultures and primary cells.
Main Results:
- Adiponectin deficiency exacerbated white matter damage and impaired axonal conduction.
- AdipoRon treatment improved long-term white matter integrity and cognitive function in mice.
- Adiponectin and adipoRon protected oligodendrocytes, enhanced microglial debris clearance, and promoted oligodendrocyte regeneration in vitro and in vivo.
Conclusions:
- Adiponectin strengthens white matter integrity in VCID, presenting a novel therapeutic target.
- Adiponectin may act by enhancing oligodendrocyte survival and promoting a reparative microglial phenotype.
- AdipoRon's benefits are mediated through microglia-dependent mechanisms, highlighting their role in white matter repair.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...